EFDID: 303014EFD: View Filing

Issuer: Summit Therapeutics plc (0001599298) - D

Accession: 0001599298-19-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001599298
  • Entity Name:
    Summit Therapeutics plc
  • Entity Type:
    Corporation
  • Jurisdiction:
    UNITED KINGDOM
  • Year of Inc:
    Over 5 years ago
  • Address:
    136A EASTERN AVENUE
    MILTON PARK
    ABINGDON, X0 OX14 4SB
  • Persons:
    Related Persons 6
    Glyn Edwards
    Executive Officer, Director
    David Roblin
    Executive Officer
    Frank Armstrong
    Director
    Leopoldo Zambeletti
    Director
    Valerie Andrews
    Director
    David Wurzer
    Director
EDGAR: Offering Information
  • Accession Date:
    01/18/2019
  • First Sale Date:
    01/09/2019
  • Offering Amount:
    $25,000,000
  • Amount Sold:
    $25,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Summit Therapeutics plc/s/ Glyn EdwardsGlyn EdwardsChief Executive Officer2019-01-18